R21AI044340 (SCHNELL, MATTHIAS JOHANNES)Sep 30, 1998 - Sep 29, 2000 NIH RABIES VIRUS BASED VECTORS AS AN HIV1 VACCINE Role: Principal Investigator |
|
R21AI049153 (SCHNELL, MATTHIAS JOHANNES)Mar 15, 2001 - May 31, 2005 NIH Rabies Virus-Based Vectors as an HIV -1 Vaccine Role: Principal Investigator |
|
R01AI049153 (SCHNELL, MATTHIAS JOHANNES)Mar 15, 2001 - Feb 28, 2010 NIH Rabies Virus-Based Vectors as an HIV-1 Vaccine Role: Principal Investigator |
|
R21AI051170 (SCHNELL, MATTHIAS JOHANNES)Jul 1, 2002 - Jun 30, 2005 NIH Prime/Boost Immunization against HIV-1 by Viral Vectors Role: Principal Investigator |
|
R21AI062807 (SCHNELL, MATTHIAS JOHANNES)Jul 5, 2005 - Jun 30, 2008 NIH Killed Rhabdoviruses as Novel Anthrax Vaccines Role: Principal Investigator |
|
R01MH074375 (SCHNELL, MATTHIAS JOHANNES)Sep 15, 2005 - Aug 31, 2009 NIH Astrocytes and Restricted HIV-1 Replication Role: Principal Investigator |
|
R41AI063822 (SCHNELL, MATTHIAS JOHANNES)Apr 15, 2006 - Mar 31, 2009 NIH A novel rhabdovirus-based anthrax vaccine Role: Principal Investigator |
|
R41AI073064 (SCHNELL, MATTHIAS JOHANNES)Apr 1, 2008 - Sep 30, 2010 NIH A novel vaccine: botulinum neurotoxin subunit on a viral carrier. Role: Principal Investigator |
|
R21AI081388 (SCHNELL, MATTHIAS JOHANNES)Jun 1, 2009 - May 31, 2012 NIH Bat rabies virus in its natural host Role: Principal Investigator |
|
P01AI082325 (SCHNELL, MATTHIAS JOHANNES)Sep 1, 2009 - Aug 31, 2012 NIH Functional Analysis of NSV-based HIV vectors Role: Principal Investigator |
|
R21NS074006 (SCHNELL, MATTHIAS JOHANNES)Jul 1, 2011 - Jun 30, 2015 NIH Fate of neurons following immune-mediated viral clearance Role: Principal Investigator |
|
R42AI073064 (SCHNELL, MATTHIAS JOHANNES)Jun 21, 2012 - May 31, 2016 NIH A novel vaccine: botulinum neurotoxin subunit on a viral carrier. Role: Principal Investigator |
|
R01AI105204 (SCHNELL, MATTHIAS JOHANNES)Feb 1, 2013 - Jan 31, 2020 NIH Preclinical characterization of a multivalent killed Filovirus/Rabies vaccine Role: Principal Investigator |
|
R01AI127823 (SCHNELL, MATTHIAS JOHANNES)Nov 15, 2016 - Oct 31, 2020 NIH Drug discovery against lyssaviruses by high thoughput screening Role: Principal Investigator |
|
R01AI123272 (SCHNELL, MATTHIAS JOHANNES)Nov 22, 2016 - Oct 31, 2021 NIH Development of a single-dose rabies virus vaccine Role: Principal Investigator |
|
R21AI128175 (SCHNELL, MATTHIAS JOHANNES)Dec 1, 2016 - Nov 30, 2019 NIH Toward an Pan-lyssavirus vaccine Role: Principal Investigator |
|
R21AI135361 (SCHNELL, MATTHIAS JOHANNES)May 16, 2018 - Apr 30, 2021 NIH Development of Rabies-based Virus-like Particles Role: Principal Investigator |
|
T32AI134646 (SCHNELL, MATTHIAS JOHANNES;SIGAL, LUIS J)Sep 1, 2018 - Aug 31, 2023 NIH Training grant on Vaccines and Immunotherapies for Infectious Diseases and Cancer Role: Co-Principal Investigator |
|
R01AI149795 (SCHNELL, MATTHIAS JOHANNES)Jan 1, 2020 - Dec 31, 2025 NIH Pan-lyssavirus therapeutics and mechanisms of protection against lyssaviruses Role: Principal Investigator |
|
R21AI158044 (SCHNELL, MATTHIAS JOHANNES)Jul 16, 2020 - Jun 30, 2022 NIH Toward a protective Covid-19 vaccine utilizing an established vector platform Role: Principal Investigator |
|
R01AI154542 (PAL, UTPAL)Jul 20, 2020 - Jun 30, 2026 NIH Multivalent Tick-Microbe targeted Lyme disease vaccines Role: Co-Principal Investigator |
|
R01AI167295 (SCHNELL, MATTHIAS JOHANNES)Aug 25, 2022 - Jul 31, 2026 NIH Analysis of a novel Crimean-Congo hemorrhagic fever vaccine and its mechanism of protection in rodent models Role: Principal Investigator |